CSIMarket Company Name, Ticker, Customers, else..


Lineage Cell Therapeutics Inc   (NYSE: LCTX)
Other Ticker:  
 

Lineage Cell Therapeutics Inc

LCTX's Fundamental analysis



Looking into Lineage Cell Therapeutics Inc growth rates, revenue grew by 203.29 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2658

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Lineage Cell Therapeutics Inc net loss decreased from $-7 millions, to $-3 millions in III. Quarter 2024,

• More on LCTX's Growth


Lineage Cell Therapeutics Inc
realized a net loss in trailing twelve months.

Lineage Cell Therapeutics Inc realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.26.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.3.


• More on LCTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 23.85
 Tangible Book Value (Per Share $) 0.04

Lineage Cell Therapeutics Inc
realized net loss in trailing twelve months.

Lineage Cell Therapeutics Inc realized cash outflow of $ -0.02per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.26.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.3.

Lineage Cell Therapeutics Inc Price to Book Ratio is at 1.52 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on LCTX's Valuation

•  Market Capitalization (Millions $) 98
•  Shares Outstanding (Millions) 189
•  Employees -
•  Revenues (TTM) (Millions $) 9
•  Net Income (TTM) (Millions $) -20
•  Cash Flow (TTM) (Millions $) -4
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 23.85
•  Tangible Book Value (Per Share $) 0.04

•  Market Capitalization (Millions $) 98
•  Shares Outstanding (Millions) 189
•  Employees -
•  Revenues (TTM) (Millions $) 9
•  Net Income (TTM) (Millions $) -20
•  Cash Flow (TTM) (Millions $) -4
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 2.48
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 4.01
•  Asset Turnover Ratio (TTM) 0.09
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com